Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biotech Deals Stand Out In 2018 Korean Licensing Trends

Jan 07 2019

• By Jung Won Shin

Businesswoman receiving or presenting gifts — Korean Biotech Licensing Deals Rise In 2018

Related Content

Dong-A Ties With NeuroBo For Diabetic Neuropathy, Alzheimer's

Jan 19 2018

SK Acquires AMPAC, On Track To Meet Global Contract Manufacturing Ambitions

Jul 16 2018

Deal Watch: Roche Goes All-In On Real-World Data With Flatiron Acquisition

Feb 19 2018

Kolmar Korea Eyes Pharma Expansion Via CJ HealthCare Acquisition

Feb 22 2018

Kolon Bounces Back From Failed Japan Invossa Deal With Bigger Mundipharma Alliance

Nov 20 2018

Yuhan Strikes Long-Awaited Lung Cancer Deal Through Huge Janssen Alliance

Nov 06 2018

Roivant Buoys Anti-Infective Portfolio With Novel iNtRON Asset

Nov 21 2018

Deal Watch: Emergent Strikes Again, Acquiring Adapt And Its Opioid Overdose Drug For $635m

Aug 29 2018

Yuhan Licenses Out Degenerative Disc Therapy To Spine Despite Earlier Trial Failure

Aug 01 2018

Deal Watch, Focus On Asia: Cipla Licenses India Rights To Lilly’s Basalgar

Jun 19 2018

Deal Watch: BioCryst Shareholder Dissent Scuttles Planned Merger With Idera

Jul 13 2018

Oncology, Diabetes Dominate Korean Out-Licensing But Deals And Value Decline

Jul 05 2018

Related Companies

Hanmi Pharmaceutical Co., Ltd.

Yuhan Corporation

ABL Bio Corp.

iNtRON Biotechnology, Inc.

Johnson & Johnson

Roivant Sciences Ltd.

TRIGR Therapeutics, Inc

Kolon Life Science, Inc.

Mundipharma International Limited

Mitsubishi Tanabe Pharma Corporation

JW Pharmaceutical Corporation

LEO Pharma A/S

Dong-A Socio Holdings

SK Chemicals Co., Ltd.

Sanofi

CG Invites Co., Ltd.

Additional Topics

South Korea Asia Pacific Deals Commercial BioPharmaceutical

More from South Korea

More from Focus On Asia

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.